Synonyms: compound 46 [PMID: 20451379] | ML-265 | ML265 | TEPP46
Compound class:
Synthetic organic
|
|
References |
1. Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, Tempel W, Dimov S, Shen M, Jha A et al.. (2012)
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol, 8 (10): 839-47. [PMID:22922757] |
2. Angiari S, Runtsch MC, Sutton CE, Palsson-McDermott EM, Kelly B, Rana N, Kane H, Papadopoulou G, Pearce EL, Mills KHG et al.. (2020)
Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity. Cell Metab, 31 (2): 391-405.e8. DOI: 10.1016/j.cmet.2019.10.015 [PMID:31761564] |
3. Fan F, Wood KV. (2007)
Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol, 5 (1): 127-36. [PMID:17355205] |
4. Jiang J, Walsh MJ, Brimacombe KR, Anastasiou D, Yu Y, Israelsen WJ, Hong BS, Tempel W, Dimov S, Veith H et al.. (2010)
ML265: A potent PKM2 activator induces tetramerization and reduces tumor formation and size in a mouse xenograft model. Probe Reports from the NIH Molecular Libraries Program,. [PMID:23905203] |
5. Jiang JK, Boxer MB, Vander Heiden MG, Shen M, Skoumbourdis AP, Southall N, Veith H, Leister W, Austin CP, Park HW et al.. (2010)
Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorg Med Chem Lett, 20 (11): 3387-93. [PMID:20451379] |